ANEBOTCPharmaceutical PreparationsFiscal year ends June 30
Anebulo Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Dec 31, 2025Last filing: 10-Q on Feb 12, 2026
$0.00+0.00 (+75.00%)
Close on Oct 19, 2026
- Market cap
- $28.76K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Anebulo Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2026 | Jan 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 26, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2025 | Dec 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 12, 2025 | Sep 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2025 | Jul 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 4, 2025 | Apr 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 6, 2025 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2025 | Feb 24, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 14, 2025 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 22, 2024 | Dec 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 17, 2024 | Oct 17, 2024 | SEC EDGAR |
| Annual report | 10-K | Jun 30, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2024 | Jul 22, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 17, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 15, 2024 | SEC EDGAR |
| Current report | 8-K | May 15, 2024 | May 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2023 | Feb 13, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2024 | Feb 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 20, 2023 | Nov 21, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 14, 2023 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2023 | Nov 14, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 30, 2023 | Oct 30, 2023 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2023 | Oct 6, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 26, 2023 | Sep 29, 2023 | SEC EDGAR |